Skip to main content
  • Home

Monthly archive

  • August 2012 (10)
  • July 2012 (31)
  • June 2012 (32)
  • May 2012 (12)
  • April 2012 (6)
  • March 2012 (20)
  • February 2012 (24)
  • January 2012 (8)
  • December 2011 (25)
  • November 2011 (5)
  • October 2011 (3)
  • September 2011 (1)
  • June 2011 (3)
Follow us:
  • facebook
  • twitter
  • YouTube

 

  • Popular
  • Recent
  • Tags
  • Three bellwether trials against Merck scheduled for 2012

    • Dec 27, 2011
  • Injection restores sight

    • Jul 26, 2012
  • Johnson & Johnson agrees to label Extra Strength Tylenol® with stronger warnings

    • Nov 18, 2011
  • Bisphosphonate drugs may not lower cancer risk

    • Jun 7, 2012
  • Avaira contact lens recall expanded

    • Dec 22, 2011
  • Take Fosamax and other bisphosphonates for 5+ years and break your thigh bone

    • May 24, 2012
  • FDA issues warning after codeine kills children post-surgery

    • Aug 16, 2012
  • Artificial retina gives sight to blind mice

    • Aug 16, 2012
  • Lucentis approved for diabetic macular edema

    • Aug 14, 2012
  • Mayo Clinic: Patients in the dark about prescriptions

    • Aug 9, 2012
  • Hospital's plan to prevent painkiller abuse

    • Aug 8, 2012
  • Alzheimer's drug disappoints

    • Aug 8, 2012
Adderall meningitis Roche metal on metal hip replacement Zocor Avaira Actos venous thromboembolism Video Games listeria Products Urban blood thinner FDA bladder cancer Johnson & Johnson lawsuits dabigatran metal-on-metal hip replacement Johnson & Johnson lawsuits lorcaserin statin Medicaid Warfarin blood thinners Bayer Nexavar colon cancer kidney problems prescription drugs

More Dangerous Drug News

Lipitor Type 2 Diabetes Lawsuit

Get News Updates By Email

@ConsumerDrugRep Tweets

Archives

  • June 2011 (3)
  • September 2011 (1)
  • October 2011 (3)
  • November 2011 (5)
  • December 2011 (25)
  • January 2012 (8)
  • February 2012 (24)
  • March 2012 (20)
  • April 2012 (6)
  • May 2012 (12)

Pages

  • 1
  • 2
  • next ›
  • last »
Sunday, 26 July 2026
  • Subscribe by RSS
Consumer Drug Report
  • Tylenol
  • Miscellaneous
    • Avaira
  • Antidepressants
  • Fosamax
  • Pradaxa
  • Actos
  • Yaz
About Us

From side effects to recalls to pending lawsuits, Consumer Drug Report keeps you up to date with the latest information on pharmaceutical safety.

To submit questions or story ideas, please post on our Consumer Drug Report Facebook page,

tweet at us @ConsumerDrugRep, or

email us at news@consumer-drug-report.com.

Details

Home

About

Contact

Privacy

Sitemap 

Disclaimer

Categories
  • Actos
  • Antidepressants
  • Avaira
  • Fosamax
  • Miscellaneous
  • Pradaxa
  • Tylenol
  • Yaz

Brought to you by Spangenberg Shibley & Liber, LLP © 2012